JP2023512442A5 - - Google Patents
Info
- Publication number
- JP2023512442A5 JP2023512442A5 JP2022542486A JP2022542486A JP2023512442A5 JP 2023512442 A5 JP2023512442 A5 JP 2023512442A5 JP 2022542486 A JP2022542486 A JP 2022542486A JP 2022542486 A JP2022542486 A JP 2022542486A JP 2023512442 A5 JP2023512442 A5 JP 2023512442A5
- Authority
- JP
- Japan
- Prior art keywords
- cdr
- seq
- complex according
- complex
- oligonucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062959788P | 2020-01-10 | 2020-01-10 | |
| US62/959,788 | 2020-01-10 | ||
| US202062965740P | 2020-01-24 | 2020-01-24 | |
| US62/965,740 | 2020-01-24 | ||
| US202062968761P | 2020-01-31 | 2020-01-31 | |
| US62/968,761 | 2020-01-31 | ||
| US202063055513P | 2020-07-23 | 2020-07-23 | |
| US63/055,513 | 2020-07-23 | ||
| US202063061833P | 2020-08-06 | 2020-08-06 | |
| US63/061,833 | 2020-08-06 | ||
| US202063132929P | 2020-12-31 | 2020-12-31 | |
| US63/132,929 | 2020-12-31 | ||
| PCT/US2021/012719 WO2021142275A1 (en) | 2020-01-10 | 2021-01-08 | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023512442A JP2023512442A (ja) | 2023-03-27 |
| JP2023512442A5 true JP2023512442A5 (https=) | 2024-01-17 |
Family
ID=76788742
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022542486A Pending JP2023512442A (ja) | 2020-01-10 | 2021-01-08 | 顔面肩甲上腕型筋ジストロフィーを処置するための筋標的化複合体およびそれらの使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230088865A1 (https=) |
| EP (1) | EP4087924A4 (https=) |
| JP (1) | JP2023512442A (https=) |
| KR (1) | KR20220125801A (https=) |
| CN (1) | CN115349013B (https=) |
| AU (1) | AU2021205492A1 (https=) |
| BR (1) | BR112022013603A2 (https=) |
| CA (1) | CA3163299A1 (https=) |
| IL (1) | IL294480A (https=) |
| MX (1) | MX2022008538A (https=) |
| WO (1) | WO2021142275A1 (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202100928QA (en) | 2018-08-02 | 2021-02-25 | Dyne Therapeutics Inc | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
| US12097263B2 (en) | 2018-08-02 | 2024-09-24 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| US12370264B1 (en) | 2018-08-02 | 2025-07-29 | Dyne Therapeutics, Inc. | Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject |
| US12018087B2 (en) | 2018-08-02 | 2024-06-25 | Dyne Therapeutics, Inc. | Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject |
| US11911484B2 (en) | 2018-08-02 | 2024-02-27 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| CA3108282A1 (en) | 2018-08-02 | 2020-02-06 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| US11168141B2 (en) | 2018-08-02 | 2021-11-09 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| JP7780691B2 (ja) * | 2020-01-10 | 2025-12-05 | ダイン セラピューティクス，インコーポレーテッド | ジストロフィン異常症を処置するための筋標的化複合体およびそれらの使用 |
| AU2021206234A1 (en) * | 2020-01-10 | 2022-09-01 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| WO2021188390A1 (en) | 2020-03-19 | 2021-09-23 | Avidity Biosciences, Inc. | Compositions and methods of treating facioscapulohumeral muscular dystrophy |
| KR20230023612A (ko) | 2020-04-02 | 2023-02-17 | 마이레큘, 인크. | 조작된 올리고뉴클레오티드를 사용한 표적화된 억제 |
| US11969475B2 (en) | 2021-07-09 | 2024-04-30 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
| JP2024525608A (ja) | 2021-07-09 | 2024-07-12 | ダイン セラピューティクス，インコーポレーテッド | ジストロフィン異常症を処置するための筋標的化複合体および製剤 |
| US11771776B2 (en) | 2021-07-09 | 2023-10-03 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| US11638761B2 (en) | 2021-07-09 | 2023-05-02 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophy |
| US11633498B2 (en) | 2021-07-09 | 2023-04-25 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| US11672872B2 (en) | 2021-07-09 | 2023-06-13 | Dyne Therapeutics, Inc. | Anti-transferrin receptor antibody and uses thereof |
| CN118265544A (zh) | 2021-09-16 | 2024-06-28 | 艾维迪提生物科学公司 | 治疗面肩肱型肌营养不良的组合物和方法 |
| AU2022377070A1 (en) * | 2021-11-01 | 2024-04-11 | Dyne Therapeutics, Inc. | Muscle targeting complexes for treating dystrophinopathies |
| TW202345894A (zh) * | 2022-01-07 | 2023-12-01 | 美商密瑞克公司 | 靶向表現於肌肉細胞表面的蛋白質之組織特異性顯像及治療劑 |
| IL316143A (en) | 2022-04-15 | 2024-12-01 | Dyne Therapeutics Inc | Muscle targeting complexes and formulations for the treatment of myotonic dystrophy |
| AU2024299328A1 (en) | 2023-07-21 | 2026-01-22 | Marrow Therapeutics, Inc. | Hematopoietic cell targeting conjugates and related methods |
| WO2025160275A1 (en) | 2024-01-24 | 2025-07-31 | Arrowhead Pharmaceuticals, Inc. | Anti-transferrin receptor antibodies, conjugates thereof, and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7241444B2 (en) * | 2002-01-18 | 2007-07-10 | Pierre Fabre Medicament | Anti-IGF-IR antibodies and uses thereof |
| EP2736539B1 (en) * | 2011-07-25 | 2017-08-23 | Nationwide Children's Hospital, Inc. | Recombinant virus products and methods for inhibition of expression of dux4 |
| WO2013120038A2 (en) * | 2012-02-10 | 2013-08-15 | Regents Of The University Of Minnesota | Morpholino targeting dux4 for treating fshd |
| BR112014020826A8 (pt) * | 2012-02-24 | 2017-09-19 | Stem Centrx Inc | Anticorpo que se liga especificamente a um epítopo, ácido nucleico, vetor ou célula hospedeira, conjugado de fármaco anticorpo, composição farmacêutica compreendendo o referido anticorpo, uso do mesmo, kit e método de preparação do conjugado |
| EP2961770A1 (en) * | 2013-02-26 | 2016-01-06 | Roche Glycart AG | Bispecific t cell activating antigen binding molecules |
| DK3473270T5 (da) * | 2016-06-20 | 2024-09-09 | Genahead Bio Inc | Konjugat af antistof-lægemiddel |
| MX2019008199A (es) * | 2017-01-06 | 2019-11-25 | Avidity Biosciences Llc | Composiciones de acido nucleico polipeptido y metodos de induccion de la omision de exon. |
| MX2020003130A (es) * | 2017-09-22 | 2020-09-25 | Avidity Biosciences Inc | Composiciones y metodos de induccion de salto de exon en acidos nucleicos-polipeptidos. |
| AU2018378812B2 (en) * | 2017-12-06 | 2025-05-22 | Avidity Biosciences, Inc. | Compositions and methods of treating muscle atrophy and myotonic dystrophy |
| SG11202100928QA (en) * | 2018-08-02 | 2021-02-25 | Dyne Therapeutics Inc | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
-
2021
- 2021-01-08 KR KR1020227027137A patent/KR20220125801A/ko active Pending
- 2021-01-08 CN CN202180019466.4A patent/CN115349013B/zh active Active
- 2021-01-08 CA CA3163299A patent/CA3163299A1/en active Pending
- 2021-01-08 US US17/791,697 patent/US20230088865A1/en active Pending
- 2021-01-08 BR BR112022013603A patent/BR112022013603A2/pt unknown
- 2021-01-08 AU AU2021205492A patent/AU2021205492A1/en active Pending
- 2021-01-08 WO PCT/US2021/012719 patent/WO2021142275A1/en not_active Ceased
- 2021-01-08 EP EP21738616.8A patent/EP4087924A4/en active Pending
- 2021-01-08 MX MX2022008538A patent/MX2022008538A/es unknown
- 2021-01-08 IL IL294480A patent/IL294480A/en unknown
- 2021-01-08 JP JP2022542486A patent/JP2023512442A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023512442A5 (https=) | ||
| JP2023510351A5 (https=) | ||
| JP2023512441A5 (https=) | ||
| JP2023509793A5 (https=) | ||
| JP2024501872A5 (https=) | ||
| JP2021533200A5 (https=) | ||
| JP2021533199A5 (https=) | ||
| JP2023535078A5 (https=) | ||
| IL317871A (en) | Muscle targeting complexes and their uses for the treatment of FACIOSCAPULOHUMERAL muscular dystrophy | |
| JP2023535444A5 (https=) | ||
| JP2023510350A5 (https=) | ||
| JP7803926B2 (ja) | ジストロフィン異常症を処置するための筋標的化複合体およびそれらの使用 | |
| JP2021533197A5 (https=) | ||
| JP2021532832A5 (https=) | ||
| JP2022513482A5 (https=) | ||
| CN115349013B (zh) | 肌肉靶向复合物及其用于治疗面肩肱型肌营养不良的用途 | |
| JP2025067909A5 (https=) | ||
| JP2023535073A5 (https=) | ||
| CA3226307A1 (en) | Muscle targeting complexes and uses thereof for treating dystrophinopathies | |
| JP2023535074A5 (https=) | ||
| JP2021533198A5 (https=) | ||
| JP2022122928A5 (https=) | ||
| JP2024527362A5 (https=) | ||
| IL274906B2 (en) | Compositions and methods for treating muscular dystrophy and myotonic dystrophy | |
| IL319265A (en) | Anti-transferrin receptor antibodies and their uses |